High Court re-confirms Actavis approach for determining claim scope of variants
Fisher & Paykel Healthcare Ltd v Resmed Ltd  EWHC 2748 (10 November 2017)
Hot on the heels of the Supreme Court’s ruling in Eli Lilly v Actavis UK Ltd (see our full analysis here), the High Court has confirmed for the second time that the “Actavis approach” is now the law for determining claim scope of variants.
Our partner Alvin Lam has written a brief analysis of the case, available here. This article was first published by Lexis®PSL on 17 November 2017.
For questions about this matter or related issues, please contact our Partner Alvin Lam (firstname.lastname@example.org).
Friday, November 24, 2017